New Jersey Gov. Chris Christie's secret gastric band surgery in February has stolen front-page headlines today. His weight is often the target of comedic fodder, but it was a legitimate concern surrounding his overall health.
This news has gotten the political media stirring that the governor is planning a White House run in 2016, but here at the Fool we're more concerned with investing than with politics. With more than 200,000 stomach-shrinking procedures performed per year, is there money to be made for investors?
In this video, Motley Fool health-care analyst David Williamson takes a closer look at the companies and highlights why this may be no slam-dunk for investors.
Follow David on Twitter: @MotleyDavid.
David Williamson has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.